Chronic hyponatremia in a patient with renal salt wasting and without cerebral disease: relationship between RSW, risk of fractures and cognitive impairment

Internal and Emergency Medicine - Tập 13 - Trang 1167-1171 - 2018
Vittoriano Della Corte1, Antonino Tuttolomondo1, Rosaria Pecoraro1, Antonio Pinto1
1U.O.C di Medicina Interna con Stroke Care, Dipartimento Biomedico di Medicina Interna e Specialistica (Di.Bi.M.I.S), University of Palermo, Palermo, Italy

Tóm tắt

Renal salt wasting syndrome (RSW) is defined as a renal loss of sodium leading to hyponatremia and a decrease in extracellular fluid volume (ECV). Differentiation of this disorder from the syndrome of inappropriate antidiuretic hormone secretion (SIADH), a common cause of hyponatremia, can be difficult because both can present with hyponatremia and concentrated urine with natriuresis. Our clinical case about a 78-year-old woman with a recent fracture of the right femur not only confirms that this syndrome can occur in patients without intracranial pathologies (CT documented), but depicts how the hyponatremia caused by RSW can show a chronic, oscillating course. This is an interesting point of view because it suggests to us to consider RSW in the differential diagnosis of patients with chronic hyponatremia.

Tài liệu tham khảo

Peters JP, Welt LG, Sims EA, Orloff J, Needham J (1950) A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians 63:57–64 Schwartz WB, Bennett W, Curelop S, Bartter FC (1957) A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 23(4):529–542 Maesaka JK, Miyawaki N, Palaia T, Fishbane S, Durham JHC (2007) Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia. Kidney Int 71(8):822–826 Epub 2007 Feb 21 Taylor P, Dehbozorgi S, Tabasum A, Scholz A, Bhatt H, Stewart P, Kumar P, Draman MS, Watt A, Rees A, Hayhurst C, Davies S (2017) Cerebral salt wasting following traumatic brain injury. Endocrinol Diabetes Metab Case Rep 2017:16–0142 Oruckaptan HH, Ozisik P, Akalan N (2000) Prolonged cerebral salt wasting syndrome associated with the intraventricular dissemination of brain tumors. Report of two cases and review of the literature. Pediatr Neurosurg 33(1):16–20 Cerdà-Esteve M, Cuadrado-Godia E, Chillaron JJ, Pont-Sunyer C, Cucurella G, Fernández M, Goday A, Cano-Pérez JF, Rodríguez-Campello A, Roquer J (2008) Cerebral salt wasting syndrome: review. Eur J Intern Med 19(4):249–254 Epub 2008 Mar 7 Oh JY, Shin JI (2014) Syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome: similarities and differences. Front Pediatr 2:146 Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G (2008) Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 101:583–588 Renneboog B, Musch W, Vandemergel X, Mantu MU, Cedaux G (2006) Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119:711–718 Schrier R (2010) Does “asymptomatic hyponatremia” exist? Nat Rev Nephrol 6(4):185 Fujisawa H, Sugimura Y, Takagi H, Mizoguchi H, Takeuchi H, Izumida H, Nakashima K, Ochiai H, Takeuchi S, Kiyota A, Fukumoto K, Iwama S, Takagishi Y, Hayashi Y, Arima H, Komatsu Y, Murata Y, Oiso Y (2016) Chronic hyponatremia causes neurologic and psychologic impairments. J Am Soc Nephrol 27(3):766–780 Barsony J, Sugimura Y, Verbalis JG (2011) Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss. J Biol Chem 286(12):10864–10875 Kavalci C, Genchallac H, Durukan P, Cevik Y (2011) Value of biomarker-based diagnostic test in differential diagnosis of hemorrhagicischemic stroke. Bratisl Lek Listy 112:398–401 Ewers M, Mielke MM, Hampel H (2010) Blood-based biomarkers of microvascular pathology in Alzheimer’s disease. Exp Gerontol 45:75–77 Sinđić A, Dobrivojević M, Hirsch JR (2011) Natriuretic peptides in brain physiology. Transl Neurosci 2:246 Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM (2009) Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 191:341–366 Fujikawa H, Kanno T, Nagata T, Nishizaki T (2008) The phosphodiesterase III inhibitor olprinone inhibits hippocampal glutamate release via a cGMP/PKG pathway. Neurosci Lett 448:208–211 Gallo EF, Iadecola C (2011) Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase. J Neurosci 31:6947–6955 Cao LH, Yang XL (2008) Natriuretic peptides and their receptors in the central nervous system. Prog Neurobiol 84:234–248 Kondo E, Yasoda A, Fujii T, Nakao K, Yamashita Y, Ueda-Sakane Y, Kanamoto N, Miura M, Arai H, Mukoyama M, Inagaki N, Nakao K (2015) Increased bone turnover and possible accelerated fracture healing in a murine model with an increased circulating C-type natriuretic peptide. Endocrinology 156(7):2518–2529